Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.